Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #451 to #500.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Authorized limit‏‎ (2 revisions)
  2. Cardiac arrhythmias‏‎ (2 revisions)
  3. Clonogenic survival‏‎ (2 revisions)
  4. Prevailing circumstances‏‎ (2 revisions)
  5. Disposal‏‎ (2 revisions)
  6. Radon Recommendations for Authorities‏‎ (2 revisions)
  7. Dose criteria‏‎ (2 revisions)
  8. Reference individual‏‎ (2 revisions)
  9. Remedial action‏‎ (2 revisions)
  10. Environmental exposure‏‎ (2 revisions)
  11. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  12. Exempt waste‏‎ (2 revisions)
  13. Intervention Level‏‎ (2 revisions)
  14. Adaptive response‏‎ (2 revisions)
  15. Substantial radiation dose level‏‎ (2 revisions)
  16. Alveolar-interstitial region‏‎ (2 revisions)
  17. Autoimmune disease‏‎ (2 revisions)
  18. Transfer rate‏‎ (2 revisions)
  19. Multi-detector computed tomography‏‎ (2 revisions)
  20. ICRP Publication 118‏‎ (2 revisions)
  21. Cardiac valve diseases‏‎ (2 revisions)
  22. Percutaneous coronary intervention‏‎ (2 revisions)
  23. Principle of application of dose limits‏‎ (2 revisions)
  24. DRL process‏‎ (2 revisions)
  25. Radioactivity‏‎ (2 revisions)
  26. Radon Recommendations for Workplaces‏‎ (2 revisions)
  27. Reference level‏‎ (2 revisions)
  28. Remediation‏‎ (2 revisions)
  29. Environmental radiation protection‏‎ (2 revisions)
  30. Risk of Exposure to Radon‏‎ (2 revisions)
  31. Exemption level‏‎ (2 revisions)
  32. South Atlantic anomaly‏‎ (2 revisions)
  33. Interventional procedure‏‎ (2 revisions)
  34. Lymphatic system‏‎ (2 revisions)
  35. Transforming growth factor‏‎ (2 revisions)
  36. Co-expertise‏‎ (2 revisions)
  37. Pericarditis‏‎ (2 revisions)
  38. Connective tissue‏‎ (2 revisions)
  39. Effective dose equivalent‏‎ (2 revisions)
  40. Repopulation‏‎ (2 revisions)
  41. Routine monitoring‏‎ (2 revisions)
  42. ICRPædia Guide to Radon‏‎ (2 revisions)
  43. Existing exposure situation‏‎ (2 revisions)
  44. Special (non-routine) monitoring‏‎ (2 revisions)
  45. Gastroschisis‏‎ (2 revisions)
  46. Lifetime risk‏‎ (2 revisions)
  47. Angiogenesis‏‎ (2 revisions)
  48. Macrophage colony stimulating factor‏‎ (2 revisions)
  49. Hyperbaric oxygen‏‎ (2 revisions)
  50. Multiplicative risk projection model‏‎ (2 revisions)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)